William Harris Investors’s iShares Biotechnology ETF IBB Stock Holding History

William Harris Investors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-3,408	Closed	-$296K	–	98
2016 Q1	$296K	Hold	3,408	–	–	0.07%	68
2015 Q4	$384K	Sell	3,408 -756	-18%	-$82.1K	0.09%	64
2015 Q3	$421K	Sell	4,164 -744	-15%	-$89.2K	0.12%	62
2015 Q2	$604K	Sell	4,908 -1,842	-27%	-$221K	0.17%	60
2015 Q1	$773K	Hold	6,750	–	–	0.2%	53
2014 Q4	$683K	Sell	6,750 -693	-9%	-$67.3K	0.18%	52
2014 Q3	$679K	Hold	7,443	–	–	0.2%	46
2014 Q2	$638K	Sell	7,443 -525	-7%	-$41.4K	0.18%	51
2014 Q1	$628K	Sell	7,968 -2,142	-21%	-$178K	0.18%	47
2013 Q4	$765K	Hold	10,110	–	–	0.23%	45
2013 Q3	$706K	Hold	10,110	–	–	0.22%	46
2013 Q2	$586K	Buy	+10,110	New	+$584K	0.18%	52

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Societe Generale $14.1B AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

William Harris Investors's IBB Position: Q2 2016 in Review

William Harris Investors sold out of iShares Biotechnology ETF (IBB) in Q2 2016, closing a stake of 3,408 shares — an estimated $296K sold.

William Harris Investors first reported a position in IBB in Q2 2013 and held it in 12 quarters. The position peaked at $773K in Q1 2015. 429 funds tracked by Wall St. Rank hold IBB as of Q2 2016.

William Harris Investors reported no remaining iShares Biotechnology ETF position as of Q2 2016 after selling out during the quarter.
William Harris Investors sold 3,408 iShares Biotechnology ETF shares in Q2 2016, an estimated $296K.
William Harris Investors first reported a position in iShares Biotechnology ETF in Q2 2013 and held it in 12 quarters.
William Harris Investors's iShares Biotechnology ETF position peaked at $773K in Q1 2015.
429 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2016.

Based on William Harris Investors's 13F filing for Q2 2016, filed 5 Aug 2016.